These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30415581)

  • 1. Efficacy of phospholipidated curcumin in nonalcoholic fatty liver disease: a clinical study.
    Panahi Y; Kianpour P; Mohtashami R; Soflaei SS; Sahebkar A
    J Asian Nat Prod Res; 2019 Aug; 21(8):798-805. PubMed ID: 30415581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial.
    Saberi-Karimian M; Keshvari M; Ghayour-Mobarhan M; Salehizadeh L; Rahmani S; Behnam B; Jamialahmadi T; Asgary S; Sahebkar A
    Complement Ther Med; 2020 Mar; 49():102322. PubMed ID: 32147075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial.
    Rahmani S; Asgary S; Askari G; Keshvari M; Hatamipour M; Feizi A; Sahebkar A
    Phytother Res; 2016 Sep; 30(9):1540-8. PubMed ID: 27270872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is There a Role for Curcumin Supplementation in the Treatment of Non-Alcoholic Fatty Liver Disease? The Data Suggest Yes.
    Zabihi NA; Pirro M; Johnston TP; Sahebkar A
    Curr Pharm Des; 2017; 23(7):969-982. PubMed ID: 27748192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial.
    Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A
    Drug Res (Stuttg); 2017 Apr; 67(4):244-251. PubMed ID: 28158893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial.
    Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A
    J Cardiovasc Pharmacol; 2016 Sep; 68(3):223-9. PubMed ID: 27124606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial.
    Panahi Y; Valizadegan G; Ahamdi N; Ganjali S; Majeed M; Sahebkar A
    J Cell Biochem; 2019 Sep; 120(9):15989-15996. PubMed ID: 31168845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin and Piperine Combination for the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled Trial.
    Mirhafez SR; Dehabeh M; Hariri M; Farimani AR; Movahedi A; Naderan RD; Jamialahmadi T; Simental-Mendía LE; Sahebkar A
    Adv Exp Med Biol; 2021; 1328():11-19. PubMed ID: 34981468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
    Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
    Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of the effect of curcumin on epigenetic changes and DNA damage among patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled, clinical trial.
    Hariri M; Gholami A; Mirhafez SR; Bidkhori M; Sahebkar A
    Complement Ther Med; 2020 Jun; 51():102447. PubMed ID: 32507446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.
    Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
    BMJ Open; 2017 Jul; 7(7):e016914. PubMed ID: 28698350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin as adjuvant treatment in patients with non-alcoholic fatty liver (NAFLD) disease: A systematic review and meta-analysis.
    Ngu MH; Norhayati MN; Rosnani Z; Zulkifli MM
    Complement Ther Med; 2022 Sep; 68():102843. PubMed ID: 35661765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin and Biochemical Parameters in Metabolic-Associated Fatty Liver Disease (MAFLD)-A Review.
    Różański G; Kujawski S; Newton JL; Zalewski P; Słomko J
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential phospholipids as a supportive adjunct in the management of patients with NAFLD.
    Dajani AI; Abu Hammour AM; Zakaria MA; Al Jaberi MR; Nounou MA; Semrin AI
    Arab J Gastroenterol; 2015; 16(3-4):99-104. PubMed ID: 26589371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Curcumin Supplementation on Metabolic Biomarkers and Body Mass Index in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Khalili L; Nammi S
    Curr Pharm Des; 2022; 28(23):1911-1925. PubMed ID: 35345991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of non-linear resistance training and curcumin supplementation on the liver biochemical markers levels and structure in older women with non-alcoholic fatty liver disease.
    Moradi Kelardeh B; Rahmati-Ahmadabad S; Farzanegi P; Helalizadeh M; Azarbayjani MA
    J Bodyw Mov Ther; 2020 Jul; 24(3):154-160. PubMed ID: 32825982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of curcumin on visfatin and zinc-α2-glycoprotein in a rat model of non-alcoholic fatty liver disease.
    Li C; Li J; Chen Y; Zhong X; Kang M
    Acta Cir Bras; 2016 Nov; 31(11):706-713. PubMed ID: 27982256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin.
    Feng WW; Kuang SY; Tu C; Ma ZJ; Pang JY; Wang YH; Zang QC; Liu TS; Zhao YL; Xiao XH; Wang JB
    Biomed Pharmacother; 2018 Mar; 99():325-333. PubMed ID: 29353208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Wei Z; Liu N; Tantai X; Xing X; Xiao C; Chen L; Wang J
    Hepatol Int; 2019 May; 13(3):302-313. PubMed ID: 30446932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.